MabVax Therapeutics Holdings Inc (OTCQB:MBVX)

3.61
Data as of Oct 29
 0.00 / 0.00%
Today’s Change
1.01
Today|||52-Week Range
17.20
-62.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$6.3M

Company Description

MabVax Therapeutics Holdings, Inc. is a clinical stage oncology drug development company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.

Contact Information

MabVax Therapeutics Holdings, Inc.
11588 Sorrento Valley Road
San Diego California 92121
P:(858) 259-9405
Investor Relations:

Employees

Shareholders

Other institutional7.07%
Mutual fund holders0.12%
Individual stakeholders--

Top Executives

John David HansenPresident, Chief Executive Officer & Director
Gregory P. HansonChief Financial Officer
Philip O. LivingstonDirector & Chief Science Officer

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.